Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

TARLIGE FILM-COATED TABLET 5 MG [SIN17574P]

Active ingredients: MIROGABALIN BESILATE EQV. MIROGABALIN

View product's general information
Last updated 16 September 2026

Product Info

TARLIGE FILM-COATED TABLET 5 MG

[SIN17574P]

Product information

Active Ingredient and Strength

MIROGABALIN BESILATE EQV. MIROGABALIN - 5 MG

Dosage Form

TABLET, FILM COATED

Manufacturer and Country

TAIYO PHARMA TECH CO., LTD., TAKATSUKI PLANT - JAPAN

Registration Number

SIN17574P

Licence Holder

A. MENARINI SINGAPORE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

N02BF03

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

2. INDICATIONS

Treatment of neuropathic pain in adults (See clinical studies section – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

Dosing

3. DOSAGE AND ADMINISTRATION

Administer mirogabalin at an initial oral dose of 5 mg twice daily, and then increase the dose by 5 mg per dosing with an interval of at least 1 week up to 15 mg twice daily. The dose may be increased or decreased appropriately in the range between 10 mg and 15 mg twice daily, based on individual patient age or symptoms.

Contraindications

16. CONTRAINDICATIONS

Patients with a history of hypersensitivity to any ingredients of TARLIGE